I agree that this site is using cookies. You can find further informations here.
X
Rowinsky, Eric K.
138  results:
Search for persons X
?
1

LOAd703, an oncolytic virus-based immunostimulatory gene th..:

Musher, Benjamin L ; Rowinsky, Eric K ; Smaglo, Brandon G...
The Lancet Oncology.  25 (2024)  4 - p. 488-500 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Phase 1 study of the protein deubiquitinase inhibitor VLX15..:

Rowinsky, Eric K. ; Paner, Agne ; Berdeja, Jesus G....
Investigational New Drugs.  38 (2020)  5 - p. 1448-1453 , 2020
Link: https://doi.org/10.1007/..
 
?
3

SL‐401 and SL‐501, targeted therapeutics directed at the in..:

Frolova, Olga ; Benito, Juliana ; Brooks, Chris...
British Journal of Haematology.  166 (2014)  6 - p. 862-874 , 2014
Link: https://doi.org/10.1111/..
 
?
4

A phase II randomized study of cetuximab and bevacizumab al..:

Ko, Andrew H. ; Youssoufian, Hagop ; Gurtler, Jayne...
Investigational New Drugs.  30 (2011)  4 - p. 1597-1606 , 2011
Link: https://doi.org/10.1007/..
 
?
5

Targeting the target of rapamycin (TOR): looking to mother ..:

Rowinsky, Eric K.
Targeted Oncology.  6 (2011)  1 - p. 1-4 , 2011
Link: https://doi.org/10.1007/..
 
?
6

The effect of bexarotene on atorvastatin pharmacokinetics: ..:

Wakelee, Heather A. ; Takimoto, Chris H. ; Lopez-Anaya, Arturo...
Cancer Chemotherapy and Pharmacology.  69 (2011)  2 - p. 563-571 , 2011
Link: https://doi.org/10.1007/..
 
?
7

A phase I pharmacokinetic study of bexarotene with paclitax..:

Rodon, Jordi ; Jacobs, Charlotte D. ; Chu, Quincy...
Cancer Chemotherapy and Pharmacology.  69 (2011)  3 - p. 825-834 , 2011
Link: https://doi.org/10.1007/..
 
?
8

Phase I and pharmacokinetic study of 3′-C-ethynylcytidine (..:

Hammond-Thelin, Lisa A. ; Thomas, Melanie B. ; Iwasaki, Michiko...
Investigational New Drugs.  30 (2010)  1 - p. 316-326 , 2010
Link: https://doi.org/10.1007/..
 
?
9

Characterisation of the cutaneous pathology in non-small ce..:

Guttman-Yassky, Emma ; Mita, Alain ; De Jonge, Maja...
European Journal of Cancer.  46 (2010)  11 - p. 2010-2019 , 2010
Link: https://doi.org/10.1016/..
 
?
10

Rationale for the development of IMC‐3G3, a fully human imm..:

Shah, Gaurav D. ; Loizos, Nick ; Youssoufian, Hagop..
Cancer.  116 (2010)  S4 - p. 1018-1026 , 2010
Link: https://doi.org/10.1002/..
 
?
11

Vascular endothelial growth factor receptor‐1 in human canc..:

Schwartz, Jonathan D. ; Rowinsky, Eric K. ; Youssoufian, Hagop..
Cancer.  116 (2010)  S4 - p. 1027-1032 , 2010
Link: https://doi.org/10.1002/..
 
?
12

Targeting FMS‐related tyrosine kinase receptor 3 with the h..:

Youssoufian, Hagop ; Rowinsky, Eric K. ; Tonra, James.
Cancer.  116 (2010)  S4 - p. 1013-1017 , 2010
Link: https://doi.org/10.1002/..
 
?
13

A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-t..:

Valle, Juan W. ; Armstrong, Anne ; Newman, Chris...
Investigational New Drugs.  29 (2010)  5 - p. 1029-1037 , 2010
Link: https://doi.org/10.1007/..
 
?
14

Phase I, pharmacokinetic study of temsirolimus administered..:

Buckner, Jan C. ; Forouzesh, Bahram ; Erlichman, Charles...
Investigational New Drugs.  28 (2009)  3 - p. 334-342 , 2009
Link: https://doi.org/10.1007/..
 
?
15

Efficacy and safety of sorafenib in a subset of patients wi..:

Pacey, Simon ; Ratain, Mark J. ; Flaherty, Keith T....
Investigational New Drugs.  29 (2009)  3 - p. 481-488 , 2009
Link: https://doi.org/10.1007/..
 
1-15